Zimmer Biomet Spin-Off’s Share Price Plummets
Executive Summary
The share price for ZimVie, Zimmer Biomet’s spinal and dental spin-off company, dropped following its launch on NASDAQ.
You may also be interested in...
2021 Venture Investment Was Bullish – Will 2022 Be The Same?
The VC market during 2021 was frantic, cash rich and oftentimes appeared to be acting on a “buy now, ask questions later” mentality. With COVID headwinds dwindling, and emerging market uncertainties, what will 2022 bring?
Analysts Applaud Zimmer Biomet’s Dental And Spine Spin-Off, Focus On Orthopedics
Zimmer Biomet’s CEO Bryan Hanson expects the spin-off will help streamline the company and optimize resources for innovation.
Minute Insight: SonALAsense MR-Guided Ultrasound Drug-Device Combo Trials Get Green Light
SonALAsense has received Safe to Proceed letters from the FDA to begin trials of its ultrasound-activated cancer killing drug.